Pooling samples means one test can screen multiple people. Tetra Images via Getty Images

Group testing for coronavirus – called pooled testing – could be the fastest and cheapest way to increase screening nationwide

Screening multiple samples with a single test gets more people diagnosed using fewer supplies. Two health policy researchers explain how it works and how it could help the US.
A new study published in the New England Journal of Medicine, discloses the results from phase 1 of Moderna’s COVID-19 vaccine trials. YurolaitsAlbert / Getty Images

Video: An infectious disease expert explains the results from Moderna’s latest vaccine trials

The results from the phase 1 trial are a promising first step in showing that the mRNA vaccine is a viable candidate, but there are unanswered questions and it is still early in the process.
COVID-19 has been linked to neurological problems in those with severe disease. Ralwel / Getty Images

Rare neurological disorder, Guillain-Barre Syndrome, linked to COVID-19

As if the symptoms of COVID-19 were not disturbing enough, physicians have noted a rare neurological condition that emerges during some severe cases of this viral infection.
Indian health workers doing health checks in Mumbai, June 17, 2020. AP Photo/Rafiq Maqbool, File

Ending the pandemic will take global access to COVID-19 treatment and vaccines – which means putting ethics before profits

The high cost of pharmaceuticals often means only the richest patients get lifesaving medicines. As coronavirus drugs emerge, it will require hard, creative work to ensure they're available to all.
Infection fatality rate is simply the number of deaths divided by the number of infections, but finding those numbers is harder than it might seem. AP Photo/John Minchillo

How deadly is the coronavirus? The true fatality rate is tricky to find, but researchers are getting closer

The percentage of people who die from a coronavirus infection is an important number for public health experts to know. Recent estimates now put it at 0.65%, far lower than initially thought.

Video

Most Read past week

  1. Could employers and states mandate COVID-19 vaccinations? Here’s what the courts have ruled
  2. Is your neighborhood raising your coronavirus risk? Redlining decades ago set communities up for greater danger
  3. Aerosols are a bigger coronavirus threat than WHO guidelines suggest – here’s what you need to know
  4. How effective does a COVID-19 coronavirus vaccine need to be to stop the pandemic? A new study has answers
  5. How California’s COVID-19 surge widens health inequalities for Black, Latino and low-income residents

Pitch an idea

Got a news tip or article idea for The Conversation?

Tell us

Our Audience

The Conversation has a monthly audience of 18 million users, and reach of 42 million through Creative Commons republication.

Want to Write?

Write an article and join a growing community of more than 110,500 academics and researchers from 3,630 institutions.

Register now

Make a Donation

The Conversation relies on university, foundation and reader support. If you would like to help us have even better conversations, then you may like to make a one-off or on-going donation.

Donate